Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

24
Number of overlapping holdings
82.8%
% of PBE's 29 holdings also in IBB
9.6%
% of IBB's 265 holdings also in PBE
Overlap by Weight
Sector Drift (PBE minus IBB)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in PBE |
Weight in IBB |
Overlap | |
---|---|---|---|---|
AMGEN INC | 5.2% | 9.6% | 5.2% | |
VERTEX PHARMACEUTICALS INC | 5.1% | 8.6% | 5.1% | |
GILEAD SCIENCES INC | 5.1% | 8.0% | 5.1% | |
REGENERON PHARMACEUTICALS | 5.1% | 8.3% | 5.1% | |
BIOGEN IDEC INC | 5.0% | 3.5% | 3.5% |
Position Highlights (Non-Overlapping Exposures)
PBE Overweight Relative to IBB
UNITED THERAPEUTICS CORP | 3.9% | |
INCYTE CORP | 3.7% | |
BIOMARIN PHARMACEUTICAL INC | 3.5% | |
CATALENT INC | 3.1% | |
VERICEL CORPORATION | 3.0% | |
OPKO HEALTH INC | 2.7% | |
QIAGEN NV | 2.6% | |
PACIFIC BIOSCIENCES OF CALIF | 2.6% | |
AMICUS THERAPEUTICS INC | 2.6% | |
ARROWHEAD PHARMACEUTICALS, INC. | 2.6% |
PBE Underweight Relative to IBB
AMGEN INC | -4.3% | |
IQVIA HOLDINGS INC | -3.7% | |
SEATTLE GENETICS INC | -3.7% | |
MODERNA, INC. | -3.6% | |
VERTEX PHARMACEUTICALS INC | -3.5% | |
REGENERON PHARMACEUTICALS | -3.3% | |
GILEAD SCIENCES INC | -2.8% | |
METTLER-TOLEDO INTERNATIONAL | -2.4% | |
ARGENX SE ADR | -2.3% | |
ILLUMINA INC | -2.2% |